| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.2M | -41.1% |
| Cost of Revenue | $16.2M | -65.4% |
| Gross Profit | $16.0M | +107.1% |
| R&D Expense | $5.4M | +32.7% |
| SG&A Expense | $7.4M | -18.0% |
| Operating Income | -$3.4M | +74.7% |
| Interest Expense | $3K | -96.6% |
| Pre-tax Income | -$3.1M | +76.1% |
| Income Tax | $11K | -98.4% |
| Net Income | $5.1M | +137.3% |
| EPS (Basic) | $0.23 | +135.4% |
| EPS (Diluted) | $0.22 | +133.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.2M | +358.9% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $11.5M | +41.2% |
| Inventory | $5.4M | -58.9% |
| Current Assets | $50.8M | +57.8% |
| Total Assets | $52.8M | +43.0% |
| Current Liabilities | $5.6M | -32.1% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $115K | -68.4% |
| $6.8M |
| -30.2% |
| Stockholders' Equity | $46.0M | +69.3% |